HEPION PHARMACEUTICALS, INC. — Operating Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/4415eb6d-5273-4da1-998a-f15515000110/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-4.2M | 2025-01-01 – 2025-12-31 | evidence 0001493152-26-009755 |
| FY 2024 | $-19.3M | 2024-01-01 – 2024-12-31 | evidence 0001641172-25-003250 |
| FY 2023 | $-48.4M | 2023-01-01 – 2023-12-31 | evidence 0001583771-24-000003 |
| FY 2022 | $-45.5M | 2022-01-01 – 2022-12-31 | evidence 0001583771-23-000003 |
| FY 2021 | $-30.4M | 2021-01-01 – 2021-12-31 | evidence 0001583771-22-000003 |
| FY 2020 | $-20.1M | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-003836 |
| FY 2019 | $-7.8M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-061587 |
| FY 2018 | $-14.6M | 2018-01-01 – 2018-12-31 | evidence 0001104659-19-014652 |
| FY 2017 | $-20.6M | 2017-01-01 – 2017-12-31 | evidence 0001104659-19-014652 |
| FY 2016 | $-20.8M | 2015-07-01 – 2016-06-30 | evidence 0001104659-16-147194 |
| FY 2015 | $-14.0M | 2014-07-01 – 2015-06-30 | evidence 0001104659-15-067379 |
| FY 2014 | $-1.7M | 2013-07-01 – 2014-06-30 | evidence 0001047469-14-007919 |
| FY 2013 | $-942.8k | 2013-05-15 – 2014-03-31 | evidence 0001104659-14-039435 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
HEPION PHARMACEUTICALS, INC. — all facts · Revenue · Net Income